Frankfurt - Delayed Quote EUR
Sanofi (SNW.F)
92.72
-1.53
(-1.62%)
At close: April 25 at 6:21:15 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 13 | 13 |
| Avg. Estimate | 10B | 12.98B | 45.31B | 48.33B |
| Low Estimate | 9.73B | 12.71B | 43.4B | 45.75B |
| High Estimate | 10.24B | 13.2B | 48.23B | 51.39B |
| Year Ago Sales | 10.74B | 13.44B | 41.08B | 45.31B |
| Sales Growth (year/est) | -6.97% | -3.44% | 10.30% | 6.66% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SNW.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
RHO6.F Roche Holding AG
34.47
-0.27%
NOTA.F Novartis AG
96.40
+1.69%
1BAYN.MI Bayer Aktiengesellschaft
23.00
+2.04%
NOVN.SW Novartis AG
92.54
+0.59%
AZN.L AstraZeneca PLC
10,400.00
-0.42%
BAYN.DE Bayer Aktiengesellschaft
22.99
+2.27%
GSK GSK plc
37.43
-0.19%
ROG.SW Roche Holding AG
261.90
-0.15%
ABBV AbbVie Inc.
186.06
+3.15%
JNJ Johnson & Johnson
154.58
-0.23%